United States · FDA National Drug Code directory
Lorazepam
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-166_c17cc1a9-f6a9-4fcd-ba74-f7291a0e43fe
- Product NDC
- 71205-166
- Form
- TABLET
- Composition / generic term
- Lorazepam
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20071001
- Source listing expiry
- 20261231
Source-listed ingredients
- LORAZEPAM — .5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TABLET in 1 BOTTLE (71205-166-02) · 71205-166-02
- 10 TABLET in 1 BOTTLE (71205-166-10) · 71205-166-10
- 15 TABLET in 1 BOTTLE (71205-166-15) · 71205-166-15
- 30 TABLET in 1 BOTTLE (71205-166-30) · 71205-166-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →